For pain and migraine-related care, the Pain and Inflammation category can help you view nearby medicine types that may appear in care plans
For example, Wegovy received FDA approval in 2024 to reduce the risk of serious cardiovascular events in adults who have cardiovascular disease in addition to obesity or overweight
Vedolizumab, a humanized IgG1 monoclonal antibody that specifically targets the 47 integrin heterodimer without affecting 41, represents the prototypical gut-selective anti-trafficking agent approved by FDA, EMA, and PMDA based on the GEMINI trials demonstrating superior efficacy over placebo for both induction and maintenance in moderate to severe UC (GEMINI 1: 47.1% clinical response and 16.9% remission at week 6
While a 120 mg once daily dosage was shown to be effective, there is no evidence that doses greater than 60 mg/day confer additional benefit
Peptide therapy is not suitable for everyone, and prescriptions are only provided where clinically appropriate following consultation
Well-known and documented peptides like copper tripeptide are still under research to obtain more details on their effectiveness, and for the development of new treatments
